Table 3.
Points to consider for transitions in genetic service provision
| Main topics to address | Questions to address |
|---|---|
| Deepening implementation | |
| Clinical need | Is the service needed to optimize clinical practice? |
| Analytical validity and clinical validity | What is the evidence for analytical and clinical validity? |
| Clinical utility | What is the evidence for clinical utility? |
| Perceived need | |
| Stakeholder’s priority and awareness (patients, payers, doctors, etc.) | Do stakeholders perceive the need for introduction of the service? Why (not)? |
| Public priority and awareness | |
| Surveillance possibilities (economic, technical) | How will the implementation of the service be monitored? |
| Broadening implementation | |
| Learning from others | What can be learnt from similar services existing elsewhere? |
| Cooperation and communication strategies | How to ensure and maintain cooperation and communication between different stakeholders? |
| Scaling up implementation | |
| Educating stakeholders (payer, doctors, nurses) | How should the actors involved in the execution of the service be educated? |
| Public education | How to educate the public about the existence, characteristics, and implications of the service? |
| Information material for the target group | What should be the content of the information material? |
| Where should it be available? (internet, leaflets, tv, etc.) | |
| Dissemination strategies | What is the target population and how should the service be disseminated to them? |
| Availability of genetic counselling | What are the needs for information and pre and posttest counselling and how to ensure the availability for the potential users of the service? |
| Acceptability (legal, political, cultural) | What are legal, moral, and financial prerequisites that need to be met? |
| Health economic evaluation | Are the benefits outweighing the costs? |
| Continuous evaluation and quality control | How will the (quality of the) service be evaluated? |
| What are the outcome measures (user satisfaction, clinical outcome, etc.) | |
| Who will be responsible for the evaluation? | |
| Monitoring results | How will the results of the service be monitored? |
| Technology development | How to ensure that new developments/notions will be integrated in the service? |